Article Details
Retrieved on: 2025-03-06 18:59:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vilobelimab is a first-in-class monoclonal anti-human complement factor C5a antibody. ... antibodies, as well as VP1-specific mucosal-homing B cells.
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here